Pfizer Ltd has announced the following Audited results for the quarter & year ended November 30, 2006:
The Company has posted a net profit of Rs 170.00 million for the quarter ended November 30, 2006 as compared to Rs 173.70 million for the quarter ended November 30, 2005. Total Income (net of excise & sales tax) has increased from Rs 1798.20 million for the quarter ended November 30, 2005 to Rs 1828.60 million for the quarter ended November 30, 2006.
The Company has posted a net profit of Rs 1057.30 million for the year ended November 30, 2006 as compared to Rs 681.20 million for the year ended November 30, 2005. Total Income (net of excise & sales tax) has increased from Rs 6395.50 million for the year ended November 30, 2005 to Rs 7217.50 million for the year ended November 30, 2006.
The Consolidated Results for year ended November 30, 2006 are as follows:
The Group has posted a net profit of Rs 1063.30 million for the year ended November 30, 2006 as compared to Rs 707.30 million for the year ended November 30, 2005. Total Income (net of excise & sales tax) has increased from Rs 6440.90 million for the year ended November 30, 2005 to Rs 7262.60 million for the year ended November 30, 2006.
Further the Company has informed that, the Board of Directors has recommended a Dividend of Rs 12.50 (125%) per equity share of Rs 10/- each for the Financial Year ended November 30, 2006.